NCT02013206View on ClinicalTrials.gov

A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

erlotinib [Tarceva]

Erlotinib tablets taken orally once daily in the morning.

Trial Locations (11)

13274

Marseille

20089

Rozzano

20162

Milan

22045

Hamburg

28041

Madrid

94805

Villejuif

1105 AZ

Amsterdam

6229 HX

Maastricht

08035

Barcelona

08907

Barcelona

M2O 4BX

Manchester

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02013206 - A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy | Biotech Hunter | Biotech Hunter